Description
Treatment of functional symptoms of benign prostatic hyperplasia. Adjuvant treatment to bladder catheterization in acute urinary retention associated with benign prostatic hyperplasia.
Xaprost LP 10 mg
Therapeutic class: Genito-Urinary System and Sexual Hormones
DCI: Alfuzosin
Form: Extended-release tablet
Présentation : Box of 30
Additional information
| Classe Thérapeutique | |
|---|---|
| Substance active | |
| Forme |
